| Reproducibility of Computed Tomography (NCT01616264) | Universidade Federal do Rio de Janeiro | 2006-01-01 |
| Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia (NCT00306319) | Radboud University Medical Center | 2006-01-01 |
| Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA) (NCT00226434) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-01-01 |
| Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129) (NCT00115609) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-01-01 |
| Development of Tuberculosis Diagnostic Kit (NCT00311207) | Taichung Veterans General Hospital | 2005-12-01 |
| Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis (NCT00285441) | Hvidovre University Hospital | 2005-11-01 |
| A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis(TB) Subunit Vaccine (NCT01003093) | Statens Serum Institut | 2005-11-01 |
| Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy (NCT00476853) | The HIV Netherlands Australia Thailand Research Collaboration | 2005-10-01 |
| Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town (NCT00460590) | University of Oxford | 2005-10-01 |
| Service Development: Assessing Non-attendance Rates in Outpatient Clinics (NCT00129649) | Imperial College London | 2005-10-01 |
| A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG (NCT00465465) | University of Oxford | 2005-10-01 |
| TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection (NCT00164450) | Centers for Disease Control and Prevention | 2005-09-01 |
| Diagnosis of Active Tuberculosis by ELISPOT (NCT00174083) | National Taiwan University Hospital | 2005-08-01 |
| Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB. (NCT00456183) | University of Oxford | 2005-08-01 |
| Exogenous Reinfection of Tuberculosis in Taiwan (NCT00173433) | National Taiwan University Hospital | 2005-08-01 |
| PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate Period (NCT00172783) | National Taiwan University Hospital | 2005-06-01 |
| Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis (NCT00173264) | National Taiwan University Hospital | 2005-06-01 |
| TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) (NCT00107887) | Johns Hopkins University | 2005-06-01 |
| A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients (NCT00398996) | Centre for the AIDS Programme of Research in South Africa | 2005-06-01 |
| The Epidemiology of TST Change in Korea (NCT01850043) | Asan Medical Center | 2005-05-01 |
| TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis (NCT00523926) | Tibotec BVBA | 2005-05-01 |
| Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis (NCT00145184) | Harvard School of Public Health (HSPH) | 2005-05-01 |
| Tuberculosis Immunity in Children (NCT00170638) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs (NCT00201123) | NYU Langone Health | 2005-04-01 |
| Continuous Positive Airway Pressure on Tuberculosis Pleural Effusion (NCT00560521) | Universidade Federal do Rio de Janeiro | 2005-03-01 |
| Food Incentives for TB Treatment Compliance in East Timor (FITTCET) (NCT00192556) | Menzies School of Health Research | 2005-03-01 |
| Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment Patients (NCT00265226) | Ministry of Science and Technology, India | 2005-03-01 |
| Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa (NCT00096681) | CIPRA SA | 2005-02-01 |
| Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research (NCT00341042) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-04 |
| Multi-Drug Resistant Tuberculosis in Korea (NCT00341601) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-03 |
| The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes Population (NCT00266383) | National Health Research Institutes, Taiwan | 2005-01-01 |
| Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised Populations (NCT00134342) | University Health Network, Toronto | 2005-01-01 |
| A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis (NCT00317330) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-12-01 |
| Treatment of Latent TB Infection for Jailed Persons (NCT00128206) | University of California, San Francisco | 2004-11-01 |
| Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana (NCT00164281) | Centers for Disease Control and Prevention | 2004-11-01 |
| Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area (NCT00557765) | University Hospital, Geneva | 2004-10-01 |
| Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis (NCT00595907) | University Hospital, Geneva | 2004-10-01 |
| Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis (NCT00082173) | Johns Hopkins University | 2004-10-01 |
| A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts (NCT00130325) | Medical Research Council Unit, The Gambia | 2004-10-01 |
| Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis (NCT00078247) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-10-01 |
| TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment (NCT00164463) | Centers for Disease Control and Prevention | 2004-07-01 |
| Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST) (NCT00851630) | Duke University | 2004-06-01 |
| Effectiveness of the TB Contact Priority Model (NCT00149448) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-05-01 |
| Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis (NCT00396084) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-02-10 |
| Arginine as an Adjuvant Treatment Against Tuberculosis (NCT00857402) | Linkoeping University | 2004-02-01 |
| Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV (NCT00080119) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2004-02-01 |
| Treatment Adherence of Tuberculosis Medicines (NCT01471977) | Gambat Institute of Medical Sciences | 2004-01-01 |
| Study of Health Personnel and the Assistance to Patients With Tuberculosis in Hospital Environment (NCT00978510) | Sociedade Cearense de Infectologia | 2004-01-01 |
| Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers (NCT00311220) | Taichung Veterans General Hospital | 2004-01-01 |
| Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis (NCT00216333) | International Union Against Tuberculosis and Lung Diseases | 2003-12-01 |
| Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk Adolescents (NCT00233168) | San Diego State University | 2003-09-01 |
| A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously (NCT00427453) | University of Oxford | 2003-06-01 |
| Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in Senegal (NCT00412009) | Institut de Recherche pour le Developpement | 2003-05-01 |
| Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization Care (NCT00203762) | University of Cape Town | 2003-05-01 |
| A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG (NCT00427830) | University of Oxford | 2003-05-01 |
| Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children (NCT00330304) | University of Cape Town | 2003-01-01 |
| Effects of Vitamin D Supplementation on Antimycobacterial Immunity (NCT00157066) | Barts & The London NHS Trust | 2002-12-01 |
| Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries? (NCT00146302) | Bandim Health Project | 2002-11-01 |
| A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers. (NCT00423566) | University of Oxford | 2002-09-01 |
| Tuberculosis Prevention for HIV Infected Adults (NCT00057122) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-09-01 |
| Tuberculosis Treatment Shortening Trial (NCT00130247) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-04-08 |
| Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis? (NCT00214708) | Barts & The London NHS Trust | 2002-01-01 |
| Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People (NCT00052195) | Dartmouth-Hitchcock Medical Center | 2001-09-01 |
| Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection (NCT00023452) | Centers for Disease Control and Prevention | 2001-06-01 |
| Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination. (NCT00242047) | University of Cape Town | 2001-03-01 |
| Preventive Therapy for Tuberculosis in HIV Infected Persons (NCT00351702) | Tuberculosis Research Centre, India | 2001-02-01 |
| Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis (NCT00376012) | Tuberculosis Research Centre, India | 2001-02-01 |
| Expression of Tuberculosis in the Lung (NCT00201253) | University of Medicine and Dentistry of New Jersey | 2000-09-01 |
| TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance (NCT00023374) | Centers for Disease Control and Prevention | 2000-08-01 |
| TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment (NCT00023439) | Centers for Disease Control and Prevention | 2000-05-01 |
| TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine (NCT00023387) | Centers for Disease Control and Prevention | 2000-03-01 |
| Nutrition, Immunology and Epidemiology of Tuberculosis (NCT00197704) | Harvard School of Public Health (HSPH) | 2000-03-01 |
| TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB (NCT00023400) | Centers for Disease Control and Prevention | 2000-02-01 |
| TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz (NCT00023413) | Centers for Disease Control and Prevention | 1999-11-01 |
| TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis (NCT00023426) | Centers for Disease Control and Prevention | 1999-07-01 |
| TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB (NCT00023348) | Centers for Disease Control and Prevention | 1999-07-01 |
| TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen (NCT00023361) | Centers for Disease Control and Prevention | 1999-02-01 |
| Tuberculosis in HIV Infected Patients in Uganda (NCT00057421) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-11-01 |
| Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection (NCT00397709) | Hospital Virgen de la Luz | 1996-03-01 |
| Behavioral Interventions for Control of TB (NCT00005739) | Columbia University | 1995-09-01 |
| Promoting Adherence to TB Regimens in Latino Adolescents (NCT00005738) | San Diego State University | 1995-09-01 |
| TB Contact Investigation: Behavioral Intervention (NCT00005740) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-09-01 |
| Behavioral Interventions for Control of Tuberculosis (NCT00005742) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-09-01 |
| Indigenous Outreach Among Injection Drug Users to Treat and Control TB (NCT00005741) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-09-01 |
| Tuberculosis Prophylaxis in the Homeless--A Controlled Trial (NCT00005737) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-09-01 |
| Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users (NCT00004740) | National Institute on Drug Abuse (NIDA) | 1995-02-01 |
| Tuberculosis in a Multiethnic Inner City Population (NCT00005379) | NYU Langone Health | 1994-08-01 |
| A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy (NCT00402610) | Sociedad Andaluza de Enfermedades Infecciosas | 1994-01-01 |
| A Registry of Tuberculosis Cases in the CPCRA (NCT00000785) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-08-01 |
| Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections (NCT00004276) | National Center for Research Resources (NCRR) | 1990-09-01 |
| A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. (NCT00000796) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis (NCT00000950) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis (NCT01464762) | Janssen Infectious Diseases BVBA | |
| Effects of SQ109 on QTc Interval in Healthy Subjects (NCT01874314) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection (NCT00000955) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen (NCT00018083) | National Center for Research Resources (NCRR) | |
| Diagnosis of Latent Tuberculosis(TB) Infection in Health Care Workers Using TST and Whole Blood Interferon-γ Assay (NCT00962793) | Yonsei University | |
| Local Anesthesia and Tuberculin Skin Test in Infants and Children (NCT00309673) | Assistance Publique - Hôpitaux de Paris | |
| Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults (NCT00096850) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection (NCT00000959) | National Institute of Allergy and Infectious Diseases (NIAID) | |